Fig 1.
Conceptual framework for the Prevention and Care Continuum (PCC): An example of HIV infection among PWID.
Table 1.
Indicator list of metrics for monitoring the PCC.
Fig 2.
HIV prevention and care continuum for people who inject drugs in Tallinn, Estonia (2011–2016).
Fig 3.
Reported use of HIV prevention interventions among HIV positive and HIV negative people who inject drugs in Tallinn, Estonia (2011–2016) (HIV+ n = 529; HIV- n = 448).
Fig 4.
HIV prevention and care continua for combined interventions among HIV+ people who inject drugs in Tallinn, Estonia (2011–2016).
(4A - HIV+ PWID currently using only NSP; 4B - HIV+ PWID currently only in drug treatment, 4C - HIV+ PWID currently using NSP and in drug treatment, 4D - HIV+ PWID currently not using NSP and not in drug treatment).
Fig 5.
Relative decrease in infectivity and susceptibility among HIV+ and HIV- persons who inject drugs (PWID), and resulting overall reduction in acquisition risk due to the existing coverage of MAT, NSP and ART in PWID in Tallinn (median of 1000 runs).